PHARMACEUTICAL PRODUCT DEVELOPMENT INC Other Depreciation and Amortization
PHARMACEUTICAL PRODUCT DEVELOPMENT INC reported Other Depreciation and Amortization of $16.82 million for the 3-month period ending 2011-09-30, per its 10-Q filed 2011-11-02.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherDepreciationAndAmortization · last filed 2011-11-02
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC other depreciation and amortization for the quarter ending 2011-09-30 was $16.82M, a 6.96% increase year-over-year.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC other depreciation and amortization for the quarter ending 2011-06-30 was $16.92M, a 1.14% decline year-over-year.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC other depreciation and amortization for the quarter ending 2011-03-31 was $16.76M, a 1.60% decline year-over-year.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC other depreciation and amortization for the quarter ending 2010-12-31 was $15.26M, a 8.82% decline year-over-year.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC other depreciation and amortization for fiscal 2010 was $65.14M, a 2.01% increase from fiscal 2009.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC other depreciation and amortization for fiscal 2009 was $63.85M, a 7.95% increase from fiscal 2008.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC other depreciation and amortization for fiscal 2008 was $59.15M.
| Period end | Other Depreciation and Amortization 3 month | Other Depreciation and Amortization 6 month | Other Depreciation and Amortization 9 month | Other Depreciation and Amortization 12 month |
|---|---|---|---|---|
| 2011-09-30 | $16.82M 10-Q · filed 2011-11-02 | $33.74M derived: sum of 2 quarters · filed 2011-11-02 | $50.50M 10-Q · filed 2011-11-02 | $65.77M derived: sum of 4 quarters · filed 2011-11-02 |
| 2011-06-30 | $16.92M 10-Q · filed 2011-08-04 | $33.68M 10-Q · filed 2011-08-04 | $48.94M derived: sum of 3 quarters · filed 2011-08-04 | $64.67M derived: sum of 4 quarters · filed 2011-11-02 |
| 2011-03-31 | $16.76M 10-Q · filed 2011-05-03 | $32.02M derived: sum of 2 quarters · filed 2011-05-03 | $47.75M derived: sum of 3 quarters · filed 2011-11-02 | $64.86M derived: sum of 4 quarters · filed 2011-11-02 |
| 2010-12-31 | $15.26M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-25 | $30.99M derived: sum of 2 quarters · filed 2011-11-02 | $48.10M derived: sum of 3 quarters · filed 2011-11-02 | $65.14M 10-K · filed 2011-02-25 |
| 2010-09-30 | $15.73M 10-Q · filed 2011-11-02 | $32.84M derived: sum of 2 quarters · filed 2011-11-02 | $49.88M 10-Q · filed 2011-11-02 | $66.61M derived: sum of 4 quarters · filed 2011-11-02 |
| 2010-06-30 | $17.11M 10-Q · filed 2011-08-04 | $34.15M 10-Q · filed 2011-08-04 | $50.89M derived: sum of 3 quarters · filed 2011-08-04 | $67.17M derived: sum of 4 quarters · filed 2011-08-04 |
| 2010-03-31 | $17.04M 10-Q · filed 2011-05-03 | $33.77M derived: sum of 2 quarters · filed 2011-05-03 | $50.06M derived: sum of 3 quarters · filed 2011-05-03 | $65.88M derived: sum of 4 quarters · filed 2011-05-03 |
| 2009-12-31 | $16.74M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-25 | $33.02M derived: sum of 2 quarters · filed 2011-02-25 | $48.84M derived: sum of 3 quarters · filed 2011-02-25 | $63.85M 10-K · filed 2011-02-25 |
| 2009-09-30 | $16.28M 10-Q · filed 2010-11-05 | $32.10M derived: sum of 2 quarters · filed 2010-11-05 | $47.12M 10-Q · filed 2010-11-05 | |
| 2009-06-30 | $15.82M 10-Q · filed 2010-08-06 | $30.84M 10-Q · filed 2010-08-06 | ||
| 2008-12-31 | $59.15M 10-K · filed 2011-02-25 |